Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Patients get individualized therapy in Nottingham Trial
January 13th, 2005
Nottingham City Hospital Trust and Optimata, Ltd., announced an innovative study aimed at improving the treatment of breast cancer by providing patients with individualized therapies. The study aims to validate the ability of Optimata's proprietary computerized modeling technology to accurately simulate the breast cancer process in individual patients as well as predict their response to therapy. It is expected that this study will be followed by a second study, where Optimata's Virtual Cancer Patient technology (VCP) will be utilized to suggest improved dosing and scheduling regimens of breast cancer patients undergoing chemotherapy. In the latter...
Source: Women's Health Weekly (2005-01-13)
|
